Àá½Ã¸¸ ±â´Ù·Á ÁÖ¼¼¿ä. ·ÎµùÁßÀÔ´Ï´Ù.

Distribution of medical status and medications in elderly patients treated with dental implant surgery covered by national healthcare insurance in Korea

Journal of Dental Anesthesia and Pain Medicine 2017³â 17±Ç 2È£ p.113 ~ 119
ÀÌ°æÁø, ´ãÁÖ°â, ÇãÁö¼±, ¹Ú°æ¹Ì, ±è¼­¿­, ¹Ú¿ø¼­,
¼Ò¼Ó »ó¼¼Á¤º¸
ÀÌ°æÁø ( Lee Kyung-Jin ) - Yonsei University Department of Advanced General Dentistry
´ãÁÖ°â ( Dam Chu-Geum ) - Yonsei University Department of Advanced General Dentistry
ÇãÁö¼± ( Huh Ji-Sun ) - Yonsei University Department of Advanced General Dentistry
¹Ú°æ¹Ì ( Park Kyeong-Mee ) - Yonsei University Department of Advanced General Dentistry
±è¼­¿­ ( Kim Seo-Yul ) - Yonsei University Department of Advanced General Dentistry
¹Ú¿ø¼­ ( Park Won-Se ) - Yonsei University Department of Advanced General Dentistry

Abstract


Background: The purpose of this study was to investigate the distribution of systemic diseases and medications in patients older than 65 years of age who visited the hospital for implant treatment, as well as to investigate basic information about surgical complications that may occur after insured implant treatment.

Methods: A total of 126 patients over 65 years of age were treated for implant surgery from October 1, 2013 to October 30, 2016. Electronic chart review was conducted to obtain medical records, which included sex, age, systemic diseases, medication(s) being taken, and control of the medications. Five patients were excluded due to lack of medical records giving information about systemic disease.

Results: Of the 126 patients, 112 (88.9%) were taking medication due to systemic disease and 9 patients (7.1%) were not. The sex distribution was 71 women and 55 men and the highest proportion of patients were between 65 and 69 years old. The most common diseases were, from most to least frequent, hypertension, cardiovascular disease, diabetes, and osteoporosis. The drug groups that can cause major complications after dental treatment were classified as hemorrhagic, osteoporotic, and immunosuppressive agents, and were taken by 45 (35.7%), 22 (17.5%) and 4 (3.2%) patients, respectively.

Conclusion: Given that 88.9% of the elderly patients who were eligible for insurance implant treatment had systemic disease, it is necessary to carefully evaluate patients¡¯ medical histories and their general conditions in order to prevent emergencies during implant surgery.

Å°¿öµå

Aged; Dental Implants; Medical History Taking; National Health Programs; Postoperative Complications

¿ø¹® ¹× ¸µÅ©¾Æ¿ô Á¤º¸

  

µîÀçÀú³Î Á¤º¸

KCI